Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards
Clinical Pharmacokinetics · 2025
DOI: 10.1007/s40262-024-01457-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacokinetics, 2025. Verfasst von Ivan Tiryannik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Certara Predictive Technologies (CPT), Sheffield, UK. ivan.tiryannik@certara.com. Hauptthemen laut MEDLINE: Models, Biological, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme System, Cytochrome P-450 Enzyme Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: Predicting metabolic drug-drug interactions (DDIs) via cytochrome P450 enzymes (CYP) is essential in drug development, but controversy has reemerged recently about whether in vitro-in vivo extrapolation (IVIVE) using static models can replace dynamic models for some regulatory filings and label recommendations. OBJECTIVE: The aim of this study was to determine if static and dynamic models are equivalent for the quantitative prediction of metabolic DDIs arising from competitive CYP inhibition. METHODS: Drug parameter spaces were varied to simulate 30,000 DDIs between hypothetical substrates and inhibitors of CYP3A4. Predicted area under the plasma concentration-time profile ratios for substrates (AUCr = AUC(presence of precipitant)/AUC(absence of precipitant)) were compared between dynamic simulations (Simcyp® V21) and corresponding static calculations, giving an inter-model discrepancy ratio (IMDR = AUCrdynamic/AUCrstatic). Dynamic simulations were conducted using a 'population' representative and a 'vulnerable patient' representative with maximal concentration (Cmax) or average steady-state concentration (Cavg,ss) as the inhibitor driver concentrations. IMDRs outside the interval 0.8-1.25 were defined as discrepancy between models. RESULTS: The highest rate of IMDR 1.25 discrepancies in the 'population' representative was 85.9% and 3.1%, respectively, when using Cavg,ss as the inhibitor driver concentration. Using the 'vulnerable patient' representative showed the highest rate of IMDR >1.25 discrepancies at 37.8%. CONCLUSION: Static models are not equivalent to dynamic models for predicting metabolic DDIs via competitive CYP inhibition across diverse drug parameter spaces, particularly for vulnerable patients. Caution is warranted in drug development if static IVIVE approaches are used alone to evaluate metabolic DDI risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Certara Predictive Technologies (CPT), Sheffield, UK. ivan.tiryannik@certara.com.
- Centre for Applied Pharmacokinetic Research (CAPKR), The University of Manchester, Manchester, UK. ivan.tiryannik@certara.com.
- Certara Predictive Technologies (CPT), Sheffield, UK.
- Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.
- CMAX Clinical Research Pty Ltd, Adelaide, Australia.
- Centre for Applied Pharmacokinetic Research (CAPKR), The University of Manchester, Manchester, UK.
ORCID-Profile: Ivan Tiryannik, Aki T Heikkinen, Masoud Jamei, Thomas M Polasek, Amin Rostami-Hodjegan
Zitieren
APA
Tiryannik, I., Heikkinen, A. T., Gardner, I., Onasanwo, A., Jamei, M., Polasek, T. M., & Rostami-Hodjegan, A. (2025). Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-024-01457-1
Vancouver
Tiryannik I, Heikkinen AT, Gardner I, Onasanwo A, Jamei M, Polasek TM, et al. Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards. Clinical Pharmacokinetics. 2025. doi:10.1007/s40262-024-01457-1
BibTeX
@article{Tiryannik2025,
author = {Tiryannik, Ivan and Heikkinen, Aki T and Gardner, Iain and Onasanwo, Anthonia and Jamei, Masoud and Polasek, Thomas M and Rostami-Hodjegan, Amin},
title = {Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards},
journal = {Clinical Pharmacokinetics},
year = {2025},
doi = {10.1007/s40262-024-01457-1}
}
EUVIMED